In another study, 109 out of 148 samples (74%) from pancreatic cancer patients had highly expressed AGR2 protein, with an elevated expression in female patients [47], and 139 out of 195 PDAC tissue samples (72%) had a high expression of AGR2 [48]. This evidence concerns the gene AGR2 and pancreatic neoplasm.